Effectiveness of azithromycin and ciprofloxacin in the treatment of typhoid fever: a systematic review
Abstract
Typhoid fever or commonly referred to as enteric fever is a systemic disease caused by Salmonella typhi. It often occurs in developing countries due to poor sanitation. Second-line antibiotics, including ciprofloxacin, have been widely used as the first choice treatment for typhoid fever. However, S. typhi has increased resistance to second-line antibiotics, so azithromycin has become an alternative treatment for the typhoid fever. This systematic review assessed the effectiveness of azithromycin and ciprofloxacin against typhoid fever in adults. This research used the PRISMA protocol with predefined Pubmed, Proquest, and EBSCO keywords. After removing duplicates and selecting studies according to inclusion and exclusion criterias, 17 studies about the effectiveness of azithromycin and ciprofloxacin in typhoid fever in adults from 1988-2020 were gathered. Studies were evaluated using JBI Critical Appraisal Tools. The results showed that administration of azithromycin and ciprofloxacin for typhoid fever yields average length of fever (3.5 d and 4.2 d) and average length of stay (9.3 d and 10 d), respectively. The susceptibility of S. typhi to azithromycin was 99.9%, whereas a significant decrease in its susceptibility to ciprofloxacin was observed in 2017-2020, from 4% to 2%. Azithromycin showed better effectiveness than ciprofloxacin in treating typhoid fever in adults based on S. typhi’s susceptibility, average length of fever and average length of stay from 17 studies reviewed.
References
Kasper DL. Harrisons manual of medicine, 20th ed., vol. 1. McGraw-Hill Education; 2019.
Typhoid epid who [Internet]. [cited 2022 Oct 4]. Available from: https://www.who.int/news-room/fact-sheets/detail/typhoid
Bhandari J, Thada PK, DeVos E. Typhoid fever. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
https://www.ncbi.nlm.nih.gov/books/NBK557513/
Kalra SP, Naithani N, Mehta SR, Swamy AJ. Current trends in the management of typhoid fever. Med J Armed Forces India 2003; 59(2):130-5.
https://doi.org/10.1016/S0377-1237(03)80060-6
Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar typhi isolates from the Middle East and Central Asia. New Microbes New Infect 2014; 2(4):88-92.
https://doi.org/10.1002/nmi2.46
Effa EE, Bukirwa H. WITHDRAWN: Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2011; 2011(10):CD006083.
https://doi.org/10.1002/14651858.CD006083.pub3
Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999; 43(6):1441-4.
https://doi.org/10.1128/AAC.43.6.1441
Afroze SR, Rahim MA, Hasan MdM, Afroz F, Haque HF, Ahmed JU, et al. Pattern of antibiotic sensitivity in enteric fever: a tertiary care hospital experience. J Medicine 2014; 15(2):122-4.
https://doi.org/10.3329/jom.v15i2.20684
Joshi RD, Khadka S, Joshi DM, Shrestha B, Dangal G, Acharya KP, et al. Antimicrobial sensitivity trend in blood culture positive enteric fever. J Nepal Health Res Council 2018; 16(2):228-32.
Khadka S, Shrestha B, Pokhrel A, Khadka S, Joshi RD, Banjara MR. Antimicrobial resistance in Salmonella typhi isolated from a referral Hospital of Kathmandu, Nepal. Microbiol Insights 2021; 14:11786361211056350.
https://doi.org/10.1177/11786361211056350
Ali Shah SA, Nadeem M, Syed SA, Fatima Abidi ST, Khan N, Bano N. Antimicrobial sensitivity pattern of salmonella typhi: emergence of resistant strains. Cureus 2020; 12(11):e11778.
https://doi.org/10.7759/cureus.11778
Ciprofloxacin - American Chemical Society [Internet]. [cited 2022 Dec 5].
https://www.acs.org/content/acs/en/molecule-of-the-week/archive/c/ciprofloxacin.html
Conley ZC, Bodine TJ, Chou A, Zechiedrich L. Wicked: the untold story of ciprofloxacin. PLoS Pathog 2018; 14(3):e1006805.
https://doi.org/10.1371/journal.ppat.1006805
Alam MN, Haq SA, Das KK, Baral PK, Mazid MN, Siddique RU, et al. Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant salmonella. Am J Trop Med Hyg 1995; 53(3):306-11.
https://doi.org/10.4269/ajtmh.1995.53.306
Drug-Resistant Typhoid [Internet]. Take on Typhoid. [cited 2022 Nov 14].
https://www.coalitionagainsttyphoid.org/the-issues/drug-resistant-typhoid/
Jelić D, Antolović R. From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics (Basel) 2016; 5(3):29.
https://doi.org/10.3390/antibiotics5030029
Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Ralph R. Typhoid fever: issues in laboratory detection, treatment options & concerns in management in developing countries. Future Sci OA 2018; 4(6):FSO312.
https://doi.org/10.4155/fsoa-2018-0003
Amin MR, Das SK, Kabir A, Islam MR, Ahmed SM, Hasan MJ. Open label randomized controlled comparison of three alternative regimes of ciprofloxacin, azithromycin and cefixime for treatment of uncomplicated typhoid fever in Bangladesh. Mymensingh Med J 2021; 30(3):725-37.
Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, et al. A Multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 2008; 3(5):e2188.
https://doi.org/10.1371/journal.pone.0002188
Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 2000; 44(7):1855-9.
https://doi.org/10.1128/AAC.44.7.1855-1859.2000
Critical Appraisal Tools | JBI [Internet]. [cited 2022 Nov 28]. Available from: https://jbi.global/critical-appraisal-tools
Cullis J. Subject and research guides: systematic reviews: Step 6: PRISMA Flow Diagram & Screen [Internet].
https://libguides.mq.edu.au/systematic_reviews/prisma_screen
Limson BM, Littaua RT. Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever. Infection 1989; 17(2):105-6.
https://doi.org/10.1007/BF01646892
Chew SK, Monteiro EH, Lim YS, Allen DM. A 7-day course of ciprofloxacin for enteric fever. J Infect 1992; 25(3):267-71.
https://doi.org/10.1016/0163-4453(92)91519-h
Uwaydah AK, al Soub H, Matar I. Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever. J Antimicrob Chemother 1992; 30(5):707-11.
https://doi.org/10.1093/jac/30.5.707
Wallace MR, Yousif AA, Mahroos GA, Mapes T, Threlfall EJ, Rowe B, et al. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever. Eur J Clin Microbiol Infect Dis 1993; 12(12):907-10.
https://doi.org/10.1007/BF01992163
Tribble D, Girgis N, Habib N, Butler T. Efficacy of azithromycin for typhoid fever. Clin Infect Dis 1995; 21(4):1045-6.
https://doi.org/0.1093/clinids/21.4.1045
Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhria R, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999; 44(2):243-50.
https://doi.org/10.1093/jac/44.2.243
Liberti A, Loiacono L. Ciprofloxacin versus chloramphenicol in the treatment of Salmonella infection. Int J Antimicrob Agents 2000; 16(3):347-8.
https://doi.org/10.1016/s0924-8579(00)00262-4
Gasem MH, Keuter M, Dolmans WMV, Van Der Ven-Jongekrijg J, Djokomoeljanto R, Van Der Meer JWM. Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. Antimicrob Agents Chemother 2003; 47(5):1727-31.
https://doi.org/10.1128/AAC.47.5.1727-1731.2003
Zmora N, Shrestha S, Neuberger A, Paran Y, Tamrakar R, Shrestha A, et al. Open label comparative trial of mono versus dual antibiotic therapy for typhoid fever in adults. PLoS Negl Trop Dis 2018; 12(4):e0006380.
https://doi.org/10.1371/journal.pntd.0006380
Harichandran D, Dinesh K. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10:97-101.
https://doi.org/10.2147/IDR.S126209
Bhetwal A, Maharjan A, Khanal PR, Parajuli NP. Enteric fever caused by Salmonella enterica serovars with reduced susceptibility of fluoroquinolones at a community based teaching Hospital of Nepal. Int J Microbiol 2017; 2017:2869458.
https://doi.org/10.1155/2017/2869458
Veeraraghavan B, Pragasam AK, Ray P, Kapil A, Nagaraj S, Perumal SPB, et al. Evaluation of antimicrobial susceptibility profile in Salmonella typhi and Salmonella paratyphi A : presenting the current scenario in India and strategy for future management. J Infect Dis 2021; 224(Supple 5):S502–16.
https://doi.org/10.1093/infdis/jiab144
Sandman Z, Iqbal OA. Azithromycin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
http://www.ncbi.nlm.nih.gov/books/NBK557766/
Thai T, Salisbury BH, Zito PM. Ciprofloxacin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
https://www.ncbi.nlm.nih.gov/books/NBK535454/
Singlas E. Clinical pharmacokinetics of azithromycin. Pathol Biol (Paris) 1995; 43(6):505-11.
Marchello CS, Birkhold M, Crump JA. Complications and mortality of typhoid fever: a global systematic review and meta-analysis. J Infect 2020; 81(6):902-10.
